Cargando…
Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis
Metastatic cancer accounts for 90% of all cancer-related deaths and continues to be one of the toughest challenges in cancer treatment. A growing body of data indicates that S100A9, a major regulator of inflammation, plays a central role in cancer progression and metastasis, particularly in the lung...
Autores principales: | Chung, Young Hun, Ortega-Rivera, Oscar A., Volckaert, Britney A., Jung, Eunkyeong, Zhao, Zhongchao, Steinmetz, Nicole F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614828/ https://www.ncbi.nlm.nih.gov/pubmed/37844250 http://dx.doi.org/10.1073/pnas.2221859120 |
Ejemplares similares
-
Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications
por: Chung, Young Hun, et al.
Publicado: (2020) -
S100A9‐Targeted Cowpea Mosaic Virus as a Prophylactic and Therapeutic Immunotherapy against Metastatic Breast Cancer and Melanoma
por: Chung, Young Hun, et al.
Publicado: (2021) -
COVID-19 vaccines based on viral nanoparticles displaying a conserved B-cell epitope show potent immunogenicity and a long-lasting antibody response
por: Affonso de Oliveira, Jessica Fernanda, et al.
Publicado: (2023) -
S100A8/A9 and S100A9 reduce acute lung injury
por: Hiroshima, Yuka, et al.
Publicado: (2017) -
Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy
por: Gautam, Aayushma, et al.
Publicado: (2021)